Peptides9 min read
Thymosin beta-4 for dry eye: what the trial’s main results showed
What thymosin beta-4 eye-drop trials found about comfort, surface staining and why favorable secondary findings do not replace missed main outcomes.
Read articleBlog
Research, explained. Explore peptides, supplements and hormone health with clear, practical breakdowns of what the studies actually tell us.
Peptides articles
All articlesMetabolism, recovery and emerging research
Peptides9 min read
What ARA-290 sarcoidosis research can tell people with other neuropathies
Similar burning or tingling symptoms do not make different neuropathies interchangeable. ARA-290 research is most useful when its study populations and outcomes are matched carefully to the clinical question.
Read article
Peptides9 min read
ARA-290 and corneal nerve imaging: what an eye scan can tell us
Why nerve trials examine the cornea, what the images measure, and how ARA-290's structural findings differ from pain relief.
Read article
Peptides9 min read
Why kisspeptin's libido research does not establish a universal aphrodisiac
Kisspeptin-54 studies offer promising signals in selected participants. Desire, arousal, distress and everyday wellbeing remain distinct outcomes.
Read article
Peptides9 min read
Why reproductive peptides need outcome-specific monitoring
Reproductive peptide monitoring works only when measurements match the intended outcome, from pituitary hormone release to sperm production, ovulation and sexual wellbeing.
Read article
Peptides7 min read
Bremelanotide long-term study: what RECONNECT adds
The 52-week RECONNECT extension adds longer observation, but its open-label design, attrition and intermittent exposure shape what it can establish.
Read article
Peptides8 min read
PT-141 in men: what the human studies actually tested
Early male PT-141 studies exist, but their erectile-response findings do not turn the women's HSDD trials into a male treatment regimen.
Read article
Peptides9 min read
LL-37 wound trials: what healing means beyond a photograph
What the LL-37 wound trials found, why circulation care matters, and how confirmed closure differs from a better-looking photograph.
Read article
Peptides10 min read
Retatrutide and muscle preservation: what body-composition data can settle
Retatrutide's human DXA substudy found substantial fat loss. Learn why lean mass, strength, and long-term muscle preservation are different questions.
Read article
Peptides9 min read
Cagrilintide and food noise: meaningful experience, difficult measurement
Food noise matters, but hunger, cravings, food thoughts and brain imaging measure different things. New CagriSema findings need careful attribution.
Read article
Peptides9 min read
Pemvidutide trial dropouts: what tolerability adds to the weight-loss story
Symptoms, treatment stops and missing measurements tell different parts of pemvidutide's clinical story.
Read article
Peptides9 min read
Thymosin beta-4 skin-wound trials: why wound type changes the answer
Topical thymosin beta-4 studies tested three different wound conditions. Their actual comparisons explain why a broad skin-repair claim goes too far.
Read article193–204 of 321 articles